Ing Groep Nv Pfizer Inc Transaction History

Ing Groep Nv

$14.4 Billion
Q1 2024

A detailed history of Ing Groep Nv transactions in Pfizer Inc stock. As of the latest transaction made, Ing Groep Nv holds 794,286 shares of PFE stock, worth $22.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

794,286

Previous 1,047,948 24.21%

Holding current value

$22.2 Million

Previous $30.2 Million 26.94%

% of portfolio

0.15%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $6.57 Million - $7.54 Million	-253,662 Reduced 24.21%	794,286 $22 Million
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $1.56 Million - $2.03 Million	59,719 Added 6.04%	1,047,948 $30.2 Million
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $14.1 Million - $16.5 Million	-440,695 Reduced 30.84%	988,229 $32.8 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $24.8 Million - $28.6 Million	-685,302 Reduced 32.41%	1,428,924 $52.4 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $21.8 Million - $28.3 Million	552,478 Added 35.38%	2,114,226 $86.3 Million

Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $27 Million - $35.3 Million	647,900 Added 70.9%	1,561,748 $80.1 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $4.8 Million - $5.86 Million	-109,673 Reduced 10.72%	913,848 $40 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $4.71 Million - $5.58 Million	101,119 Added 10.96%	1,023,521 $53.7 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $9.01 Million - $11.2 Million	196,987 Added 27.16%	922,402 $47.8 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $10.6 Million - $15.7 Million	256,273 Added 54.63%	725,415 $42.8 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $119,987 - $154,133	-3,057 Reduced 0.65%	469,142 $20.2 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $3.45 Million - $3.91 Million	96,055 Added 25.54%	472,199 $18.5 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $4,822 - $5,438	144 Added 0.04%	376,144 $13.6 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $5.08 Million - $6.45 Million	151,645 Added 67.59%	376,000 $13.8 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $1.83 Million - $2.15 Million	57,757 Added 34.67%	224,355 $8.23 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $4.52 Million - $5.48 Million	-150,005 Reduced 47.38%	166,598 $5.45 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $7.4 Million - $10.6 Million	-273,856 Reduced 46.38%	316,603 $10.3 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $4.1 Million - $4.65 Million	-124,480 Reduced 17.41%	590,459 $23.1 Million
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $20.3 Million - $26.3 Million	-625,279 Reduced 46.66%	714,939 $25.7 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $34.8 Million - $39 Million	939,842 Added 234.74%	1,340,218 $58.1 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $17.8 Million - $19.6 Million	-475,002 Reduced 54.26%	400,376 $17 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $9.33 Million - $10.6 Million	-242,578 Reduced 21.7%	875,378 $38.2 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $470,446 - $570,622	-13,648 Reduced 1.21%	1,117,956 $49.3 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $23.4 Million - $24.9 Million	708,742 Added 167.61%	1,131,604 $41.1 Million
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $21 Million - $24.4 Million	-658,515 Reduced 60.9%	422,862 $15 Million
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $32.6 Million - $34.6 Million	-980,370 Reduced 47.55%	1,081,377 $39.2 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $63.9 Million - $70.4 Million	2,061,747	2,061,747 $73.6 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account